HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A follow-up study on effects of ADL deterioration on QOL in patients with neurological intractable diseases].

AbstractOBJECTIVE:
This follow-up study examined correlating factors, including change of activity of daily living (ADL), which are associated with subjective quality of life (QOL) in patients with neurological intractable diseases such as amyotrophic lateral sclerosis, spinocerebellar degeneration and Parkinson disease.
METHODS:
Baseline information of 159 patients with above mentioned three intractable diseases registered by two public health centers in Niigata and Fukuoka Prefectures was obtained in 1993-1994, and they were followed to 1995. At the end of follow-up, 124 subjects were interviewed by public health nurses using the 27 item-subjective QOL scale for patients with neurological intractable diseases, previously confirmed for reliability and validity.
RESULTS:
Low level of ADL at the time of registry and deterioration of ADL after the registry were independently related to low level of subjective QOL.
CONCLUSIONS:
It may be necessary to minimize the ADL deterioration, in order to maintain a high subjective QOL of patients with neurological intractable diseases.
AuthorsT Iizuka, Y Ogata, M Minowa, T Fujita
Journal[Nihon koshu eisei zasshi] Japanese journal of public health (Nihon Koshu Eisei Zasshi) Vol. 46 Issue 8 Pg. 595-603 (Aug 1999) ISSN: 0546-1766 [Print] Japan
PMID10496028 (Publication Type: English Abstract, Journal Article)
Topics
  • Activities of Daily Living
  • Aged
  • Amyotrophic Lateral Sclerosis (physiopathology)
  • Female
  • Follow-Up Studies
  • Humans
  • Interviews as Topic
  • Male
  • Middle Aged
  • Nervous System Diseases (physiopathology)
  • Parkinson Disease (physiopathology)
  • Quality of Life
  • Spinocerebellar Degenerations (physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: